Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Atrial Fibrillation (AF)
Session type:
Tutorials
Sponsored by Bristol Myers Squibb and Pfizer
Date:
27 August 2021
Time:
17:30
-
18:30
Session
This content is currently on OPEN ACCESS
1 presentations in this session
Management of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation (NVAF) who are older and frail, with moderate renal impairment and multiple comorbidities.
Speaker:
Associate Professor R. Collins (Dublin, IE)
Speaker:
Doctor J. Cosin Sales (Valencia, ES)
2 speakers from this session
Associate Professor Ronan
Collins
Tallaght University Hospital, Dublin (Ireland)
7
presentations
0
follower
Doctor Juan
Cosin Sales
HOSPITAL ARNAU DE VILANOVA, Valencia (Spain)
3
presentations
0
follower
Related content
ESC Premium Access
Controversy: can we propose atrial fibrillation ablation as first line therapy?
4 December 2021
This platform is supported by
